Viagra and Pharma Sector : A Speculative Investment ?

The original success of Viagra has left a peculiar shadow over the overall pharmaceutical landscape. While copyright initially reaped substantial revenue, generic versions now erode its market dominance, presenting challenges for investors considering positions in related companies. Doubts about the sustained viability of erectile dysfunction medic

read more

Premium Gambler's Sildenafil: A Precarious Gamble

The emergence of so-called "Elite Roller Sildenafil" – often referring to exceptionally high doses ordered by rogue physicians – represents a troublingly alarming trend. While standard dosages of Sildenafil are intended for treating erectile dysfunction safely in most patients, these significantly elevated doses pose a grave threat to heart hea

read more